Allurion Technologies (ALURD) Cash from Operations Growth (3y) (2025 - 2026)

Allurion Technologies (ALURD) Cash from Operations Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn 4.78%
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn 9.30%
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 1.51%
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn -48.14%
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn -14.75%
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn 50.11%
8 Smith & Nephew 28.19 Bn 27.62 Bn - -
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn -2.37%
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn 32.12%

Historic Data

Download Data
DateValue
Mar 31, 2026 32.12%
Dec 31, 2025 30.35%
Sep 30, 2025 13.62%